NYSE: G · Information Technology Services
Genpact (G) fair value: undervalued or overvalued?
As of 31 Oct 2026, Faircurve's model values Genpact (G) at $43.47 a share. The stock last closed at $40.22, which puts the model's fair value 8.1% above the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 3 Nov 2026. Genpact Limited.
The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.
This week, in three parts
What happenedThe run of 31 Oct 2026 moved the fair value from $44.40 to $43.47 (-2.1%). The stock's own trading multiple fell with its price, and the fair value follows it in part: most of the move.
What the model makes of itThe price of $40.22 is 8.1% below it: Fairly valued, on a medium evidence grade.
What's nextReports on 5 Nov 2026. The next weekly run is on Saturday 7 Nov 2026.
What price range does the model give G?
The calibrated range for G over 63 trading days is $35.21 to $51.92. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 10,454 past valuations, refreshed 31 Oct 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $32.18 to $57.39. In 60% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 31 Oct 2026
Genpact Limited (G) is a global professional services firm specialising in business process management and information technology solutions.
Faircurve's model put the fair value at $43.47 a share on 31 Oct 2026. The previous run, on 24 Oct 2026, gave $44.40, so the fair value moved -2.1%. The model's reason, in its own words: "The stock's own trading multiple fell with its price, and the fair value follows it in part: most of the move." The calibrated range over 63 trading days is $35.21 to $51.92. It is built from the fair value, as there is no live options data for the stock. Calibrated weekly against realised prices, using 10,454 past valuations, refreshed 31 Oct 2026, ranges built this way held the price 60% of the time at this horizon. The evidence grade is Medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It does not say whether the fair value is right.
On quality, Faircurve's model gives Genpact a score of 63 out of 100 against comparable companies. Profitability is the highest factor at 81, with ROIC of 17.3% against a peer median of 11.9%. Stability scores 73, with EBITDA margin downside volatility over five years of 0.9 pts against a peer median of 2.2 pts. The model compares Genpact with Science Applications International Corporation (SAIC), ExlService Holdings, Inc. (EXLS), EPAM Systems, Inc. (EPAM), Parsons Corporation (PSN), Insight Enterprises, Inc. (NSIT), Jack Henry & Associates, Inc. (JKHY) and CACI International Inc (CACI). Gartner, Inc. (IT) is also compared, with no verdict on this date.
Written from the figures on this page for the 31 Oct 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does G report earnings, and how has the stock reacted?
Genpact's next earnings report is scheduled for 5 Nov 2026. Companies can move their dates.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across G's last 8 reports, ignoring direction, was 8.3%.
How does G score on business quality?
Genpact's overall quality score is 63 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 81 | 17.3%ROIC | 11.9% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 38 | 0.98xFCF / net income | 1.66x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 56 | 6.6%Revenue growth, trailing | 6.9% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 68 | 4.6%Net buybacks / market value | 9.3% |
| Balance sheetNet debt to EBITDA and interest coverage. | 57 | 1.01xNet debt / EBITDA | 2.27x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 73 | 0.9 ptsEBITDA margin downside volatility, 5y | 2.2 pts |
How does G compare with similar companies?
The companies in information technology services closest to Genpact in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| SAIC Science Applications International Corporation | $151.59 | $150.11 | -1.0% | Fairly valued |
| EXLS ExlService Holdings, Inc. | $42.13 | $33.89 | -19.6% | Overvalued |
| EPAM EPAM Systems, Inc. | $138.17 | $125.60 | -9.1% | Fairly valued |
| PSN Parsons Corporation | $51.76 | $61.63 | +19.1% | Undervalued |
| NSIT Insight Enterprises, Inc. | $167.35 | $156.33 | -6.6% | Fairly valued |
| JKHY Jack Henry & Associates, Inc. | $161.66 | $148.08 | -8.4% | Fairly valued |
| IT Gartner, Inc. | $204.22 | $195.61 | -4.2% | Data under review |
| CACI CACI International Inc | $680.10 | $624.16 | -8.2% | Fairly valued |
What the comparable companies' multiples alone would give for G, the peer-implied price, is $67.51 a share on this run. The fair value weighs that against the company's own multiple.
All information technology services stocks ranked by gap to fair value
Genpact at a glance
Genpact Limited (G) is a global professional services firm specializing in business process management and information technology solutions.
- Market value
- $6.7B
- Sector
- Technology
- Industry
- Information Technology Services
- Revenue expected, next twelve months
- $5.8B
- Consensus revenue growth, next fiscal year
- +7.0%
- Analysts with estimates
- 9
- Beta to the US market
- -0.08
- First valued by Faircurve
- 11 Jul 2026
At the close of 3 Nov 2026, 52.1% of the 1,081 graded US stocks the model covers traded below the model's fair value. G was among them.
How the fair value is worked out: the model prices Genpact on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 24 Oct 2026 the model's fair value for G was $44.40. As of 31 Oct 2026 it is $43.47, a change of -2.1%. The stock's own trading multiple fell with its price, and the fair value follows it in part: most of the move. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Genpact's valuation
Is Genpact stock undervalued or overvalued?
On Faircurve's model, G reads as Fairly valued as of 31 Oct 2026. The model's fair value is $43.47 a share against a last close of $40.22, a gap of +8.1%.
What is G's fair value?
$43.47 a share as of 31 Oct 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $32.18 to $57.39.
What price range does the model give G?
$35.21 to $51.92 over 63 trading days. Ranges built this way held the price 60% of the time across 10,454 past valuations, refreshed 31 Oct 2026.
When does Genpact report earnings next?
The next report is scheduled for 5 Nov 2026. Companies can move their dates.
How much has G moved on past earnings reports?
Across its last 8 reports the median two session move was 8.3%, ignoring direction. The largest was +16.2% around the report of 8 Aug 2024.
How confident is the model in this valuation?
The model's evidence grade for G is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on G
The model holds no idea open on G today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on G with their outcomes. A free account is enough.